Deepening Democracy through Access to Information
Home / News / International News RSS ← Back

Email this article

separate emails by commas, maximum limit of 4 addresses

Verification Image. Please refresh the page if you cannot see this image.

Sponsored by


Article Enquiry

WHO calls for unity in developing Covid-19 vaccine

Verification Image. Please refresh the page if you cannot see this image.

Embed Video

WHO calls for unity in developing Covid-19 vaccine

Photo by Reuters
WHO director-general Tedros Adhanom Ghebreyesus

14th August 2020

By: African News Agency


Font size: -+

The World Health Organization (WHO) said that six months after first sounding the international alarm over Covid-19, the United Nations is now intensely guiding global vaccine candidates through the necessary trials and guaranteeing rapid, fair and equitable access to them for all countries.

As the global infection rate surpasses the 20-million mark, various countries are working hard to trial and test possible vaccines for the deadly virus that has claimed more than 758 000 lives worldwide.


According to a statement issued by the United Nations, WHO director-general Tedros Adhanom Ghebreyesus said that to move forward the best bet was to do it together.

He said the Access to Covid-19 Tools (ACT) Accelerator, launched in April, had shown results, with nine vaccine candidates in the COVAX portfolio now advancing through phase 2 or 3 trials.


Meanwhile, the International Monetary Fund (IMF) has estimated that the coronavirus pandemic is costing US$375-billion a month and predicts a US$12-trillion cumulative loss to the global economy over two years.  

Furthermore, the G-20 group of leading economies has mobilised more than US$10-trillion in fiscal stimulus to treat and mitigate the consequences of the pandemic – three and a half times what the world dispensed to address the global financial crisis of 2008, said the report.

On Tuesday, Russian President Vladimir Putin announced that Russia had become the first country to grant regulatory approval to a Covid-19 vaccine, which showed "stable immunity" against the novel coronavirus, according to Al Jazeera.

The prospective vaccine has been met with much skepticism from all corners about its efficacy and safety, especially after being through just two months of human testing.


To subscribe email or click here
To advertise email or click here

Comment Guidelines

About is a product of Creamer Media.

Other Creamer Media Products include:
Engineering News
Mining Weekly
Research Channel Africa

Read more


We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store


Advertising on is an effective way to build and consolidate a company's profile among clients and prospective clients. Email

View options
Free daily email newsletter Register Now